In people with insulin resistance, insulin fails to effectively suppress the apolipoprotein C-III (ApoC-III), which is one of the most potent inhibitors of LPL, which inhibits LPL action in peripheral tissues and favors hepatic uptake of TG-rich chylomicron debris [24]. This evidence concerns the gene APOC3 and Insulin resistance.